s6y

enGene Therapeutics Inc.

Ticker
ENGN, ENGNW
CIK
1980845
Industry
Biological Products, (No Diagnostic Substances)
Formerly
enGene Holdings Inc.

Financials 14

  1. 10-Q Quarterly Report for period ending Jul 31, 2026
  2. 10-Q Quarterly Report for period ending Apr 30, 2026
  3. 10-Q Quarterly Report for period ending Jan 31, 2026
  4. 10-K/A Annual Report for period ending Oct 31, 2025
  5. 10-K Annual Report for period ending Oct 31, 2025
  6. 10-Q Quarterly Report for period ending Jul 31, 2025
  7. 10-Q Quarterly Report for period ending Apr 30, 2025
  8. 10-Q Quarterly Report for period ending Jan 31, 2025
  9. 10-K/A Annual Report for period ending Oct 31, 2024
  10. 10-K Annual Report for period ending Oct 31, 2024

All 14 financials filings

News 47

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K/A Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 47 news filings

Ownership 117

  1. 4 Statement of changes in beneficial ownership of securities
  2. 3 Initial statement of beneficial ownership of securities
  3. 4 Statement of changes in beneficial ownership of securities
  4. 3 Initial statement of beneficial ownership of securities
  5. 3 Initial statement of beneficial ownership of securities
  6. 4 Statement of changes in beneficial ownership of securities
  7. 4 Statement of changes in beneficial ownership of securities
  8. 4 Statement of changes in beneficial ownership of securities
  9. 4 Statement of changes in beneficial ownership of securities
  10. 4 Statement of changes in beneficial ownership of securities

All 117 ownership filings

Prospectus 33

  1. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  2. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  3. S-3 Registration statement for specified transactions by certain issuers
  4. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  5. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  6. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  7. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  8. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  9. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  10. 424B3 Prospectus filed pursuant to Rule 424(b)(3)

All 33 prospectus filings

Proxies 3

  1. DEF 14A Definitive proxy statements
  2. DEF 14A Definitive proxy statements
  3. DEF 14A Definitive proxy statements

Other 58

  1. SCHEDULE 13G/A
  2. SCHEDULE 13G
  3. SCHEDULE 13G/A
  4. SCHEDULE 13G/A
  5. SCHEDULE 13G/A
  6. SCHEDULE 13G/A
  7. SCHEDULE 13G/A
  8. SCHEDULE 13G
  9. SCHEDULE 13G/A
  10. SCHEDULE 13G/A

All 58 other filings